Testicular, Penile, and Rare Malignancies
Advertisement
Researchers determined the surgical efficacy of RPLND and evaluated recurrence after primary RPLND for CS IIA/IIB seminoma.
A study analyzed 228 patients with penile cancer who underwent pelvic lymph node treatment with curative intent.
Results from a single-institution trial support using surveys to inform comprehensive plans for testicular cancer survivors.
Researchers reviewed the efficacy of sentinel lymph node biopsy as well as further radical inguinal lymph node dissection.
Progression-free survival for stage IIA and stage IIB seminoma was improved with single-dose carboplatin and radiotherapy.
Hispanic males had the highest incidence of HPV-associated penile cancers and were diagnosed at later stages.
Neoadjuvant platinum-based chemotherapy has been found effective for treating metastatic penile squamous cell carcinoma.
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
Many TGCT survivors are referred for life-long monitoring due to an increased risk for skin cancer and melanoma.
In this paper, we present age-standardized cancer incidence and mortality rates in the Faroe Islands.
RLRN has been widely used in the surgical treatment of renal cancer due to small wound, less bleeding, and rapid recovery.
Arterioureteral fistulas (AUF) following ileal conduit reconstruction are rare and not well-studied.
Researchers determined the underlying oncogenic functions of hepcidin in common male genitourinary system tumors.
Hematospermia, although often found to be a benign condition, can be an alarming sign.
Synovial Sarcoma (SS) is a rare soft-tissue malignancy. Only about 15% of SS originates from the retroperitoneum.
Cisplatin is a widely used chemotherapeutic agent, but its utility is limited because of cisplatin-induced ototoxicity.
Cancer of unknown primary (CUP) is an aggressive rare malignancy with limited treatment options.
Malignant rhabdoid tumor is a rare, aggressive pediatric malignancy most commonly diagnosed in those below the age of three.
Christian Kollmannsberger gets into the Christmas spirit by discussing highlights of 2020 in the world of testis cancer.
Dr. Jan Oldenburg discusses stage 1 testis cancer treatment choices, the dilemma of high-dose therapy for relapse, and more.
Advertisement
670 Madison Ave.
Manalapan, NJ 07726